[HTML][HTML] A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants
…, SR Duncan, SJ Forman, JA Zaia… - … England Journal of …, 1991 - Mass Medical Soc
Background. Cytomegalovirus (CMV)-associated interstitial pneumonia is a major cause of
death after allogeneic bone marrow transplantation. We conducted a controlled trial of …
death after allogeneic bone marrow transplantation. We conducted a controlled trial of …
RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
…, D Hsu, SJ Forman, JJ Rossi, JA Zaia - Science translational …, 2010 - science.org
AIDS patients who develop lymphoma are often treated with transplanted hematopoietic
progenitor cells. As a first step in developing a hematopoietic cell–based gene therapy treatment…
progenitor cells. As a first step in developing a hematopoietic cell–based gene therapy treatment…
Ribozymes as potential anti-HIV-1 therapeutic agents
N Sarver, EM Cantin, PS Chang, JA Zaia, PA Ladne… - Science, 1990 - science.org
Certain RNA molecules, called ribozymes, possess enzymatic, self-cleaving activity. The
cleavage reaction is catalytic and no energy source is required. Ribozymes of the "hammerhead…
cleavage reaction is catalytic and no energy source is required. Ribozymes of the "hammerhead…
[HTML][HTML] The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell …
JA Zaia, JY Sun, GM Gallez-Hawkins, L Thao… - Biology of Blood and …, 2009 - Elsevier
It has been shown that activating killer Ig-like receptor (aKIR) genes are important for control
of cytomegalovirus (CMV) reactivation after hematopoietic cell transplantation (HCT). To …
of cytomegalovirus (CMV) reactivation after hematopoietic cell transplantation (HCT). To …
Impact of donor CMV status on viral infection and reconstitution of multifunction CMV-specific T cells in CMV-positive transplant recipients
…, R Nakamura, SJ Forman, JA Zaia… - Blood, The Journal …, 2009 - ashpublications.org
Reconstitution of cytomegalovirus (CMV)–specific CD8 + T cells is essential to the control of
CMV infection in CMV-positive recipients (R + ) after allogeneic hematopoietic stem cell …
CMV infection in CMV-positive recipients (R + ) after allogeneic hematopoietic stem cell …
Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus‐specific cytotoxic T lymphocytes
…, B Tanamachi, CR Li, JA Zaia… - Journal of medical …, 1994 - Wiley Online Library
Primary Cytomegalovirus (CMV) infection and reactivation of persistent CMV are associated
with significant morbidity and mortality in immuno‐compromised individuals. Although …
with significant morbidity and mortality in immuno‐compromised individuals. Although …
Acyclovir halts progression of herpes zoster in immunocompromised patients
…, JD Meyers, JC Wade, JA Zaia… - … England Journal of …, 1983 - Mass Medical Soc
We conducted a placebo-controlled, double-blind study of acyclovir therapy for acute herpes
zoster in immunocompromised patients. Of the 94 patients enrolled in the study, 52 had …
zoster in immunocompromised patients. Of the 94 patients enrolled in the study, 52 had …
Airborne transmission of chickenpox in a hospital
JM Leclair, JA Zaia, MJ Levin… - … England Journal of …, 1980 - Mass Medical Soc
The occurrence of chickenpox in pediatric hospitals disrupts routine care of immunologically
normal patients and is potentially life-threatening to immunosuppressed patients. …
normal patients and is potentially life-threatening to immunosuppressed patients. …
Direct detection of HIV-1 RNA from AIDS and ARC patient samples
GJ MURAKAWA, JA ZAIA, PA SPALLONE… - Dna, 1988 - liebertpub.com
Human immunodeficiency virus (HIV), formerly termed human T-lymphotropic virus (HTLVIII/LAV),
is the etiological agent of acquired immune deficiency syndrome (AIDS). Direct …
is the etiological agent of acquired immune deficiency syndrome (AIDS). Direct …
Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases
…, PD Gregory, Q Liu, MC Holmes, PM Cannon, JA Zaia… - Molecular Therapy, 2013 - cell.com
The HIV-1 coreceptor CCR5 is a validated target for HIV/AIDS therapy. The apparent elimination
of HIV-1 in a patient treated with an allogeneic stem cell transplant homozygous for a …
of HIV-1 in a patient treated with an allogeneic stem cell transplant homozygous for a …